Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Cd34 Bone Marrow Stem Cells Intravitreal

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT01736059Phase 1Active Not Recruiting

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

NCT00804102Not ApplicableCompleted

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Showing all 2 trials

Research Network

Common Treatments

  • Cd34 Bone Marrow Stem Cells Intravitreal1
  • Dtlelectrode Attached Without Energy1
  • Transcorneal Electrical Stimulation1

Active Sponsors

  • Okuvision GmbH1
  • University of California, Davis1

Top Investigators

Related Conditions

  • Retinitis Pigmentosa2
  • Macula Off1
  • Primary Open Angle Glaucoma1
  • Retina Vein Occlusion1
  • Retinal Artery Occlusion1

Activity Timeline